Assistant Member, Department of Molecular Oncology, Department of BioEngineering
Chang earned her PhD in Bioengineering from the University of Pittsburgh, focusing on the dysregulation of cytoskeleton proteins profilin1 and profilin2 in breast cancer within the laboratory of Partha Roy. She did her initial postdoctoral research under Benjamin Gewurz at Harvard Medical School, where she discovered novel CD40 signaling regulators in human B cells. Additionally, she unveiled host factors that restrict the Epstein-Barr Virus's transition from latency to lytic reactivation in human B cells. Her second postdoctoral tenure, with Gina DeNicola, centered on identifying key upstream regulators and downstream effectors of NRF2 in non-small cell lung cancer (NSCLC). In September 2023, she founded her own lab at Moffitt Cancer Center.
Research Associate II
Ryan completed his undergraduate studies at the University of South Florida, earning a Bachelor’s of Science in Cell and Molecular Biology. He continued his efforts at the USF College of Pharmacy and obtained a Master’s of Science in Pharmaceutical Nanotechnology with a focus on Drug Design, Development, and Delivery. During his Master’s coursework, he completed a thesis project investigating the potential of the Hsp90/Cdc37 chaperone complex as a druggable target for the treatment of neurodegenerative diseases. Currently, he is engaging in research at Moffitt Cancer Center to broaden his perspectives and experiences in the field of molecular biology research.
Steven Tsang is currently pursuing a Bachelor's degree in Cell and Molecular Biology with a minor in Chemistry at the University of South Florida.
Ting Chao is an undergraduate student with a major in Biomedical Sciences at the University of South Florida. She has a special interest in Chemistry and Biology and is looking to thrive on interdisciplinary research.